Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15307977 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome
Condition: Recurrent Abortion
Interventions: Drug: enoxaparin 40mg plus low dose aspirin;   Drug: Heparin calcium5,000 U twice daily plus low dose aspirin

Indicates status has not been verified in more than two years